$Bob's and Jbem's Bitchin' Bios

[ash111]

KTOV yes indeed.solid day."one step closer to NDA submission and market launch".All milestones completed exactly by the book and KTOV last step is to file NDA by end of this year. I am feeling KTOV might file earlier than expected. actually Material Events/catalysts could hit before NDA submission: a commercialization Agreement and patnet Should become official tmr. http://investorshub.advfn.com/uimage/uploads/2016/7/31/uuhlaktov.png
KTOV will have exclusive rights for many years in the US market. That's big money for any company,especially for $20m cap Co.

The company has completely zero debt and currently trading close to Cash on hand.Not to mention that Celebrex(Pfizer Drug) has major risks while kitov has an improved Celebrex .folks might drop Celebrex overnight and switch to Kitov drug and not worry about side effects. with the improved celebrex Pfizer could easily pass $2.4B(2014 sales) even $3B sales IMO. "KIT-302, has blockbuster peak annual sales potential in the United States alone": http://www.analystratings.com/2016/02/16/rodman-renshaw-initiates-a-buy-rating-on-kitov-pharmceuticals/431432/

KTOV's drug treats two diseases for the price of one.selling into multi-billion dollar markets, providing a solution to physicians hesitant to recommend NSAIDs due to heart effects, and lending significant cost savings to health care payors. "Today, there is no drug on the market that handles both things together - in pain as a result of osteoarthritis and high blood pressure. Therefore, the KIT-302 will be the only drug with indication for the treatment of pain while reducing the risk of heart attack and stroke may even brought a dying patient,"